CD274 and neoplasm: Furthermore, because an enriched tumor microenvironment suggests better immune cell infiltration, collectively, these data may explain, at least in part, why subgroup analysis of the final OS results from this trial demonstrated larger OS benefit in the PD-L1-positive population [24].